TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16601995

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 112

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 112

Group type: COMPARATOR
Intervention: Sulpiride
Number of subjects: 112
Study: 15055472

Group type: EXPERIMENTAL
Intervention: PCOS patients (n=33)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Hirsute women (PCOS and IH combined, n=73)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Women with hyperandrogenemia
Number of subjects: 93

Group type: COMPARATOR
Intervention: Healthy control subjects (n=20)
Number of subjects: 93
Study: 10942184

Group type: EXPERIMENTAL
Intervention: 400 mg pentoxifylline at 1000 hours
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 400 mg pentoxifylline at 2200 hours
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 400 mg pentoxifylline (both treatments)
Number of subjects: 12
Study: 8798112

Group type: EXPERIMENTAL
Intervention: Two-leg training group
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: One-leg training group
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 21
Study: 1616168

Group type: EXPERIMENTAL
Intervention: Omeprazole (40 mg)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Omeprazole (80 mg)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ranitidine (50 mg)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ranitidine (100 mg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no drug)
Number of subjects: 50
Study: 6611603

Group type: EXPERIMENTAL
Intervention: Bepridil 200 mg/day
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Bepridil 300 mg/day
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Bepridil 400 mg/day
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Bepridil (all dosages)
Number of subjects: 6
Study: 30079573

Group type: EXPERIMENTAL
Intervention: Intervention A (targeted at improving information provision)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Intervention B (targeted at improving collaborative goal setting)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Intervention A
Number of subjects: 37
Study: 26865514

Group type: EXPERIMENTAL
Intervention: Dichlorphenamide (DCP)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 24225126

Group type: EXPERIMENTAL
Intervention: Etomidate with flumazenil (group F, n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Etomidate without flumazenil (group E, n=20)
Number of subjects: 40
Study: 22789494

Group type: EXPERIMENTAL
Intervention: Goldmann applanation tonometry (GAT)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Static applanation resonance tonometry (ART)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Dynamic contour tonometry (DCT)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Dynamic applanation resonance tonometry (ART)
Number of subjects: 38
Study: 20345546

Group type: EXPERIMENTAL
Intervention: Mometasone furoate 50 microg once daily into each nostril for 3 months
Number of subjects: 217

Group type: COMPARATOR
Intervention: Placebo spray once daily into each nostril for 3 months
Number of subjects: 217
Study: 18280329

Group type: EXPERIMENTAL
Intervention: Preventive model targeting all children aged 6-23 months
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Recuperative model targeting underweight children aged 6-60 months
Number of subjects: 1500
Study: 15877290

Group type: EXPERIMENTAL
Intervention: High-dose growth hormone (GH) administration for 4 hours
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no GH administration)
Number of subjects: 12
Study: 12544508

Group type: EXPERIMENTAL
Intervention: Irbesartan (angiotensin II type 1 receptor blocker)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Atenolol (beta 1-adrenergic receptor blocker)
Number of subjects: 97
Study: 11827617

Group type: EXPERIMENTAL
Intervention: Cognitive and behavioral treatment including education about memory loss, relaxation training, memory skills training, and cognitive restructuring for memory-related beliefs.
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-treatment control condition
Number of subjects: 0
Study: 10481831

Group type: EXPERIMENTAL
Intervention: Pentagastrin (0 to 0.8 microgram/kg)
Number of subjects: 0
Study: 8526782

Group type: EXPERIMENTAL
Intervention: Nifedipine oros 30 mg/day
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Nifedipine oros 60 mg/day (for non-responders)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Nifedipine oros
Number of subjects: 203
Study: 2191779

Group type: EXPERIMENTAL
Intervention: Transdermal clonidine (0.2 mg daily)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Oral captopril (122.9 mg daily)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Transdermal clonidine
Number of subjects: 68

Group type: COMPARATOR
Intervention: Oral captopril
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Transdermal clonidine and Oral captopril
Number of subjects: 68
Study: 6769158

Group type: EXPERIMENTAL
Intervention: Ketotifen
Number of subjects: 36

Group type: COMPARATOR
Intervention: Disodium cromoglycate
Number of subjects: 36
Study: 31617025

Group type: EXPERIMENTAL
Intervention: Higher PPF/SCF ratio (≥ 1)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Lower PPF/SCF ratio (< 1)
Number of subjects: 85
Study: 31170680

Group type: EXPERIMENTAL
Intervention: Hépar (1 L daily for 14 days)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Low-mineral water (1 L daily for 14 days)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Hépar
Number of subjects: 226

Group type: COMPARATOR
Intervention: Low-mineral water
Number of subjects: 226
Study: 28340302

Group type: EXPERIMENTAL
Intervention: Higher energy expenditures from different types of breaks (standing, light‐ or moderate‐intensity walking)
Number of subjects: 0
Study: 25982590

Group type: EXPERIMENTAL
Intervention: Intravenous carbamazepine (administered at 70% of the oral dosage, mean 675.1 mg) infused over 30 min
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Intravenous carbamazepine (administered at 70% of the oral dosage, mean 675.1 mg) infused over 15 min
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Intravenous carbamazepine (administered at 70% of the oral dosage, mean 675.1 mg) with rapid infusions (2-5 min)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Oral carbamazepine (mean 962.5 mg)
Number of subjects: 98
Study: 23551697

Group type: EXPERIMENTAL
Intervention: Left atrial volume measurement
Number of subjects: 1758
Study: 21228335

Group type: EXPERIMENTAL
Intervention: Cetuximab plus FOLFOX-4
Number of subjects: 315
Study: 19825050

Group type: EXPERIMENTAL
Intervention: EndoFlex tracheal tube
Number of subjects: 50
Study: 18162722

Group type: EXPERIMENTAL
Intervention: Pantoprazole
Number of subjects: 164

Group type: COMPARATOR
Intervention: Famotidine
Number of subjects: 164
Study: 15166555

Group type: EXPERIMENTAL
Intervention: Remifentanil infusion of 25 ng.kg(‐1).min(‐1)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Remifentanil infusion of 50 ng.kg(‐1).min(‐1)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Remifentanil infusion of 100 ng.kg(‐1).min(‐1)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Propofol alone
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Propofol in combination with remifentanil
Number of subjects: 32
Study: 11819165

Group type: EXPERIMENTAL
Intervention: Roux-en Y reconstruction with pouch
Number of subjects: 164

Group type: COMPARATOR
Intervention: Roux-en Y reconstruction without pouch
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Isoperistaltic jejunum interposition with pouch
Number of subjects: 164

Group type: COMPARATOR
Intervention: Isoperistaltic jejunum interposition without pouch
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Roux-en Y reconstruction with jejunum interposition with pouch
Number of subjects: 164
Study: 9622434

Group type: EXPERIMENTAL
Intervention: Acamprosate
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Acamprosate with disulfiram
Number of subjects: 118
Study: 8160990

Group type: EXPERIMENTAL
Intervention: 10 micrograms of fentanyl
Number of subjects: 62

Group type: COMPARATOR
Intervention: Preservative-free normal saline (placebo group)
Number of subjects: 62
Study: 3277912

Group type: EXPERIMENTAL
Intervention: Chlorthalidone (25 mg)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Triamterene (50 mg)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Oxprenolol (160 mg)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Combination of chlorthalidone and triamterene
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Active treatment
Number of subjects: 27
Study: 30347966

Group type: EXPERIMENTAL
Intervention: Dabigatran 150 mg BID
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dabigatran 110 mg BID
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 0

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 0
Study: 27188814

Group type: EXPERIMENTAL
Intervention: 800 mg DHA/day (3 capsules daily)
Number of subjects: 2399

Group type: COMPARATOR
Intervention: Vegetable oil placebo
Number of subjects: 2399
Study: 25539637

Group type: EXPERIMENTAL
Intervention: Conversation-based cognitive stimulation delivered through personal computers, a webcam and the internet
Number of subjects: 1102

Group type: COMPARATOR
Intervention: Committed with interest group
Number of subjects: 1102
Study: 22409211

Group type: EXPERIMENTAL
Intervention: Ivabradine 7.5 mg twice daily for 5 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo twice daily for 5 days
Number of subjects: 40
Study: 20798615

Group type: EXPERIMENTAL
Intervention: Evidence-based practice in facility design
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Critical appraisal of facility design research articles
Number of subjects: 0
Study: 18684258

Group type: EXPERIMENTAL
Intervention: Low-tilt biphasic waveform
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional waveform
Number of subjects: 0
Study: 15916852

Group type: EXPERIMENTAL
Intervention: Incorrect *G condition (e.g., He happened using it)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Grammatical versions
Number of subjects: 10

Group type: COMPARATOR
Intervention: Incorrect *I condition (e.g., He postponed to use it)
Number of subjects: 10
Study: 15531473

Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) treatment at 1 or 2 mg GH/m² body surface.d (approximately 0.035 or 0.07 mg/kg.d)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) treatment
Number of subjects: 74
Study: 10882848

Group type: EXPERIMENTAL
Intervention: PKA regulatory subunits type I (RI) and type II (RII) in patients with schizophrenia
Number of subjects: 12

Group type: COMPARATOR
Intervention: PKA regulatory subunits type I (RI) and type II (RII) in controls
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Catalytic (C) subunit of PKA in patients with schizophrenia
Number of subjects: 12

Group type: COMPARATOR
Intervention: Catalytic (C) subunit of PKA in controls
Number of subjects: 12
Study: 8881628

Group type: EXPERIMENTAL
Intervention: 1% propofol
Number of subjects: 99

Group type: COMPARATOR
Intervention: 1% propofol and 0.5% methohexitone mixture
Number of subjects: 99
Study: 1529635

Group type: EXPERIMENTAL
Intervention: Graded compression stockings
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control (no stockings)
Number of subjects: 49
Study: 3924084

Group type: EXPERIMENTAL
Intervention: High-dose alfentanil anaesthesia (150 micrograms kg‐1 initially, followed by continuous infusion at a rate of 3 micrograms kg‐1 min‐1)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Neurolept anaesthesia (droperidol 0.25 mg kg‐1 plus fentanyl 5 micrograms kg‐1 initially, followed by intermittent incremental doses of fentanyl 50 micrograms)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: High-dose alfentanil anaesthesia
Number of subjects: 24
Study: 2455132

Group type: EXPERIMENTAL
Intervention: verapamil (120 mg b.i.d.)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: nifedipine (20 mg b.i.d.)
Number of subjects: 12
Study: 31439812

Group type: EXPERIMENTAL
Intervention: Niraparib 100 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Niraparib 200 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Niraparib 300 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Niraparib (all doses)
Number of subjects: 36
Study: 31619124

Group type: EXPERIMENTAL
Intervention: Outcome-based educational intervention
Number of subjects: 213

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 213
Study: 28059942

Group type: EXPERIMENTAL
Intervention: Electromyographic biofeedback (EMG-BF)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 25164268

Group type: EXPERIMENTAL
Intervention: P50 (50% maximal tolerable torque)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: P75 (75% maximal tolerable torque)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: P100 (maximum intensity without pain)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Comparison of protocols for the same time under stretch
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: P50, P75, P100
Number of subjects: 17
Study: 23497162

Group type: EXPERIMENTAL
Intervention: Progressive aquatic resistance exercise program (1-hour duration, 3 times a week for four months)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Normal care during the intervention period
Number of subjects: 80
Study: 21317163

Group type: EXPERIMENTAL
Intervention: Trial interventions (subject involvement, weekly phone reminders, routine counselling)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Routine counselling only
Number of subjects: 76
Study: 18295975

Group type: EXPERIMENTAL
Intervention: FIRST
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: MEAL
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: LAST
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: ROUTINE
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: ENHANCE
Number of subjects: 371
Study: 16525107

Group type: EXPERIMENTAL
Intervention: Ethionamide (250 mg or 500 mg, six times a week)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Prothionamide (250 mg or 500 mg, six times a week)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ethionamide (500 mg)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Prothionamide (500 mg)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Prothionamide (both dose levels)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Overall killing of M. leprae
Number of subjects: 50
Study: 12395939

Group type: EXPERIMENTAL
Intervention: 12-week multidisciplinary rehabilitation programme emphasizing physiotherapy
Number of subjects: 43

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 43
Study: 10217586

Group type: EXPERIMENTAL
Intervention: PncD (PS-protein conjugate with diphtheria toxoid)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PncT (PS-protein conjugate with tetanus protein)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PncCRM (PS-protein conjugate with CRM197 protein)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 23-valent PS vaccine (control group)
Number of subjects: 0
Study: 7788929

Group type: EXPERIMENTAL
Intervention: 200 or 400 micrograms of budesonide powder b.i.d.
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study: 2149389

Group type: EXPERIMENTAL
Intervention: Amlodipine (10 mg once daily)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 370178

Group type: EXPERIMENTAL
Intervention: Topical anesthetic 1
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Topical anesthetic 2
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Topical anesthetic 3
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 29576624

Group type: EXPERIMENTAL
Intervention: Cabozantinib (60 mg daily)
Number of subjects: 658

Group type: COMPARATOR
Intervention: Everolimus (10 mg daily)
Number of subjects: 658
Study: 26220149

Group type: EXPERIMENTAL
Intervention: Individualized dose of rapid‐acting insulin (2 ± 1 units, range 0‐4 units) administered immediately after resistance exercise
Number of subjects: 8

Group type: COMPARATOR
Intervention: No insulin administered after resistance exercise
Number of subjects: 8
Study: 24748530

Group type: EXPERIMENTAL
Intervention: Hot (35 °C/40 % rH)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Hypoxia (FiO2 0.15)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Hot + Hypoxia (35 °C/40 % rH + FiO2 0.15)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (temperate/sea level)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: All trials compounded (pre- to post-exercise)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Hot conditions
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Altitude
Number of subjects: 11
Study: 23515373

Group type: EXPERIMENTAL
Intervention: Meditation
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise
Number of subjects: 154

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 154
Study: 20567136

Group type: EXPERIMENTAL
Intervention: Exercise program for balance and muscular strength (8 weeks)
Number of subjects: 33
Study: 18383421

Group type: EXPERIMENTAL
Intervention: Intervention group (specific intervention details not available)
Number of subjects: 3311
Study: 16586336

Group type: EXPERIMENTAL
Intervention: Diet group (Group A) - weight loss of approximately 5% through self-determined means
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (Group B) - maintained body weight
Number of subjects: 20
Study: 12680735

Group type: EXPERIMENTAL
Intervention: 0.05 mg pergolide (D1/D2 receptor agonist)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 2.5 mg bromocriptine (D2 receptor agonist)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 10385642

Group type: EXPERIMENTAL
Intervention: Carvedilol (n = 14)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Propranolol (n = 14)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo (n = 7)
Number of subjects: 35
Study: 8971227

Group type: EXPERIMENTAL
Intervention: Spondylitis Functional Index (SFI) observed by physical therapists
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Spondylitis Functional Index (SFI) observed by observer 1
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Spondylitis Functional Index (SFI) observed by observer 2
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Inter-observer reliability of SFI
Number of subjects: 30
Study: 1817471

Group type: EXPERIMENTAL
Intervention: Cervex sampler
Number of subjects: 240

Group type: COMPARATOR
Intervention: Aylesbury spatula
Number of subjects: 240
Study: 7042030

Group type: EXPERIMENTAL
Intervention: Injection site in the arm
Number of subjects: 125

Group type: COMPARATOR
Intervention: Injection site in the abdomen
Number of subjects: 125
Study: 30887024

Group type: EXPERIMENTAL
Intervention: Coronary computed tomography angiography (CCTA) with CT-derived fractional flow reserve (FFRCT)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: CCTA with FFRCT
Number of subjects: 20
Study: 30518425

Group type: EXPERIMENTAL
Intervention: Audencel (dendritic cell-based immunotherapy)
Number of subjects: 0
Study: 27052110

Group type: EXPERIMENTAL
Intervention: Cryosurgery followed by ingenol mebutate (CRY + IngMeb)
Number of subjects: 329

Group type: COMPARATOR
Intervention: Cryosurgery followed by vehicle (CRY + vehicle)
Number of subjects: 329
Study: 24333009

Group type: EXPERIMENTAL
Intervention: Anastrozole 1 mg orally every day for 5 years
Number of subjects: 3864

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3864

Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 3864
Study: 22665748

Group type: EXPERIMENTAL
Intervention: Regular soft drink
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High energy drink
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Diet soft drink
Number of subjects: 20
Study: 20363596

Group type: EXPERIMENTAL
Intervention: Daily supplementation of 3.0 mmol of magnesium-chloride per kilogram of body weight in SES and SCS groups
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Daily supplementation of 3.0 mmol of magnesium-chloride per kilogram of body weight in SES group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control groups (SCS and UCS)
Number of subjects: 40
Study: 18721344

Group type: EXPERIMENTAL
Intervention: Self-adapted mouthguard (MG2)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Custom-fitted mouthguard (MG3)
Number of subjects: 11

Group type: COMPARATOR
Intervention: No mouthguard (reference)
Number of subjects: 11
Study: 16435702

Group type: EXPERIMENTAL
Intervention: Attentive navigation technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: Free navigation techniques
Number of subjects: 0
Study: 12591745

Group type: EXPERIMENTAL
Intervention: Intracardiac echocardiography (ICE)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Transesophageal echocardiography (TEE)
Number of subjects: 44
Study: 10475304

Group type: EXPERIMENTAL
Intervention: Group II (delayed recovery with propofol sedation for 2 hours)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Group I (early extubation)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 8775244

Group type: EXPERIMENTAL
Intervention: 50 mg mifepristone + 0.5 mg gemeprost
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 200 mg mifepristone + 1.0 mg gemeprost
Number of subjects: 100
Study: 1615873

Group type: EXPERIMENTAL
Intervention: Flecainide (300 mg) as a single oral loading dose
Number of subjects: 62

Group type: COMPARATOR
Intervention: Amiodarone (5 mg/kg as an intravenous bolus, followed by 1.8 g/day)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 6528619

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of heparin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subcutaneous injection of heparin
Number of subjects: 0
Study: 29130829

Group type: EXPERIMENTAL
Intervention: Phototherapy along with Kangaroo mother care (KMC)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional phototherapy
Number of subjects: 70